BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)
$3.93 0.24 (6.5041%)
Analysed BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
11-09-2026
yahoo.com
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
15-09-2026
yahoo.com
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
23-09-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
14-10-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
02-09-2026
yahoo.com
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
19-08-2026
yahoo.com
Interim results for the six months ended June 30, 2026
11-09-2026
yahoo.com
BDRX: Enrollment in Phase 3 SERENTA Trial Reaches 92 Patients
22-09-2026
yahoo.com
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
13-10-2026
yahoo.com
Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates
13-10-2026
advfn.com
What is the current price of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The current price of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is $3.93.
BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) since the previous trading day is $0.24.
BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) since the previous trading day is 6.5041%.
What is the most recent average sentiment score for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The most recent average sentiment score for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)?
The most recent sentiment for BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ) is .
SEC-8K** Filing Available For BIODEXA PHARMACEUTICALS-ADR (BDRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.